Intracerebroventricular infusion of neuropeptide Y modulates VIP secretion in the fasting conscious dog

Neuropeptides

Volumn 43, Issue 1, 2009, Pages 41-46

  Anastasiou, O E ^a   Yavropoulou, M P ^a   Kesisoglou, I ^a   Kotsa, K ^a   Yovos, J G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Glucagon; Insulin; Intracerebroventricular; NPY; VIP

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; NEUROPEPTIDE Y; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BRAIN THIRD VENTRICLE; CEREBROSPINAL FLUID; CONSCIOUSNESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET RESTRICTION; DOG; DRUG INFUSION; FEMALE; GLUCAGON RELEASE; HORMONE RELEASE; INFUSION PUMP; INJECTION; INSULIN RELEASE; MALE; MODULATION; NONHUMAN; PANCREAS; PRIORITY JOURNAL; REGULATORY MECHANISM; STEREOTACTIC PROCEDURE;

ANIMALS; BLOOD GLUCOSE; DOGS; FASTING; GLUCAGON; INJECTIONS, INTRAVENTRICULAR; INSULIN; NEUROPEPTIDE Y; VASOACTIVE INTESTINAL PEPTIDE;

CANIS FAMILIARIS;

EID: 59249106911     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.10.001     Document Type: Article

References (27)

1. Adeghate E., Ponery A.S., Pallot D.J., and Singh J. Distribution of vasoactive intestinal polypeptide, neuropeptide Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats. Peptides 22 (2001) 99-107
2. Bertrand G., Puech R., Maisonnasse Y., Bockaert J., and Loubatières-Mariani M.M. Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat. Br. J. Pharmacol. 117 (1996) 764-770
3. Billington C.J., Briggs J.E., Grace M., and Levine A.S. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260 (1991) 321-327
4. Bishop A.E., Polak J.M., Green I.C., Bryant M.G., and Bloom S.R. The location of VIP in the pancreas of man and rat. Diabetologia 18 (1980) 73-78
5. Chayvialle J.A., Miyata M., Rayford P.L., and Thompson J.C. Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs. Gastroenterology 79 (1980) 844-852
6. Cho Y.R., and Kim C.W. Neuropeptide Y promotes B cell replication via extracellular signal-regulated kinase activation. Biochem. Biophys. Res. Commun. 314 (2004) 773-780
7. Dunbar J.C., Ergene E., and Barraco R.A. Neuropeptide-Y stimulation of insulin secretion is mediated via the nucleus tractus solitarius. Horm. Metab. Res. 24 (1992) 103-105
8. Ellison E.C., Pappas T.T., Pace W.G., and O'Dorisio T.M. Apparatus for long term ventricular access in the awake canine. J. Appl. Physiol. 61 (1986) 368-372
9. Geoghegan J.G., Lawson D.C., Cheng C.A., Opara E., Taylor I.L., and Pappas T.N. Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. Gastroenterology 105 (1993) 1069-1077
10. Goodman M.H. Hormonal regulation of fuel metabolism. In: Goodman M.H. (Ed). Basic Medical Endocrinology. third ed. (2003), Elsevier 291-325
11. Guzman S., Chayvialle J.A., Banks W.A., Rayford P.L., and Thompson J.C. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide and somatostatin. Surgery 86 (1979) 329-336
12. Humphrey C.S., Murray P., Ebeid A.M., and Fischer J.E. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat. Gastroenterology 77 (1979) 55-60
13. Kuenzel W.J., and Mc Murtry J. Neuropeptide Y: brain localization and central effects on plasma insulin levels in chicks. Physiol. Behav. 44 (1988) 669-678
14. Lee M.C., Lawson D.C., and Pappas T.N. Neuropeptide Y functions as a physiologic regulator of cephalic phase acid secretion. Regul. Pept. 52 (1994) 227-234
15. Moltz J.H., and McDonald J.K. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides 6 (1985) 1155-1159
16. Norman A.W., and Litwack G. Gastrointestinal hormones. In: Norman A.W., and Litwack G. (Eds). Hormones. second ed. (1997), Elsevier 229-249
17. O'Connor A.M., Pola S., Ward B.M., Fillmore D., Buchanan K.D., and Kirwan J.P. The gastroenteroinsular response to glucose ingestion during postexercise recovery. Am. J. Physiol. Endocrinol. Metab. 290 (2006) 1155-1161
18. Sheikh S.P., Holst J.J., Skak-Nielsen T., Knigge U., Warberg J., Theodorsson-Norheim E., Hökfelt T., Lundberg J.M., and Schwartz T.W. Release of NPY in pig pancreas: dual parasympathetic and sympathetic regulation. Am. J. Physiol. 255 (1988) 46-54
19. Strubbe J.H., Prins A.J., Bruggink J., and Steffens A.B. Daily variation of food-induced changes in blood glucose and insulin in the rat and the control by the suprachiasmatic nucleus and the vagus nerve. J. Auton. Nerv. Syst. 20 (1987) 113-119
20. Szecówka J., Sandberg E., Efendić, and S. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas. Diabetologia 19 (1980) 137-142
21. Vettor R., Zarjevski N., Cusin I., Rohner-Jeanrenaud F., and Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37 (1994) 1202-1208
22. Wilding I.P., Kruszynska Y.T., Lambert P.D., and Bloom S.R. Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats. Clin. Sci. (Colch) 89 (1995) 543-548
23. Wilson D.A., O'Neill J.T., Said S.I., and Traystman R.J. Vasoactive intestinal polypeptide and the canine cerebral circulation. Circ. Res. 48 (1981) 138-148
24. Winzell M.S., and Ahrén B. Role of VIP and PACAP in islet function. Peptides 28 (2007) 1805-1813
25. Woods S.C., Porte Jr. D., Bobbioni E., Ionescu E., Sauter J.F., Rohner-Jeanrenaud F., and Jeanrenaud B. Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am. J. Clin. Nutr. 42 (1985) 1063-1071
26. Yovos J.G., O'Dorisio T.M., Gaginella T.S., Cataland S., and Carey LC. Development and validation of an in vivo brain-gut peptide model. Regul. Pept. Suppl. (1983) 222
27. Zeng N., Athmann C., Kang T., Lyu R.M., Walsh J.H., Ohning G.V., Sachs G., and Pisegna J.R. PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J. Clin. Invest. 104 (1999) 1383-1391